-
Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China
Mar 10, 2025, 14:00 PM -
Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study
Mar 10, 2025, 14:00 PM -
Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer
Mar 10, 2025, 14:00 PM -
A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review
Mar 10, 2025, 14:00 PM -
Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US
Mar 10, 2025, 14:00 PM -
Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Utilizing Machine Learning to Predict Survival Outcomes in Multiple Myeloma Patients with Diabetes: Insights from a 20-Year Cohort Study
Mar 10, 2025, 14:00 PM -
Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada
Mar 10, 2025, 14:00 PM -
No Claim Left Behind: Viability of Assessing Early Real-World Vaccine Effectiveness in Open and Closed Administrative Healthcare Claims
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Cost of Vaccine Misinformation on the US Healthcare System
Mar 10, 2025, 14:00 PM -
Characterizing Social Determinants of Health in the Population Receiving Pneumococcal Vaccine in a National Pharmacy Chain in the United States
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Chemotherapy and Radiotherapy among Non-Small Cell Lung Cancer Patients with Brain Metastases: A SEER-based Cohort Analysis
Mar 10, 2025, 14:00 PM -
Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure
Mar 10, 2025, 14:00 PM -
Comparative Efficacy and Safety of Adjunctive CT-152 in Major Depressive Disorder: A Frequentist Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes
Mar 10, 2025, 14:00 PM -
A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?
Mar 10, 2025, 14:00 PM
